Surfactant protein A detection in large cell carcinoma of the lung

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 1, 2006, Pages 88-90

  Uzaslan, Esra ^a,b   Ebsen, Michael ^a   Stuempel, Tina ^a   Freudenberg, Nikolaus ^c   Nakamura, Shinobu ^d   Costabel, Ulrich ^e   Guzman, Josune ^a,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ULUDAG UNIVERSITY   (Turkey)

^c UNIVERSITY OF FREIBURG   (Germany)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e RUHRLANDKLINIK   (Germany)

Author keywords

Immunohistochemistry; Lung large cell carcinoma; Surfactant protein A

Indexed keywords

SURFACTANT PROTEIN A;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STAINING; STATISTICAL SIGNIFICANCE; TUMOR DIFFERENTIATION;

CARCINOMA, LARGE CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A;

EID: 33645166032     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000153723.59272.02     Document Type: Article

References (34)

1. Travis WD, Colby TV, Corrin B, et al. World Health Organisation (WHO) International Histologic Classification of Tumors. Histological Typing of Lung and Pleural Tumors, 3th ed. WHO, 1999:54-55.
2. Ishida T, Kaneko S, Tateishi M, et al. Large cell carcinoma of the lung. Prognostic implications of histopathologic and immunohistochemical subtyping. Am J Clin Pathol. 1990;93:176-182.
3. Kodama T, Shimosato Y, Koide T, et al. Large cell carcinoma of the lung ultrastructural and immunohistochemical studies. Jpn J Clin Oncol. 1985;15:431-441.
4. Yesner R. Large cell carcinoma of the lung. Semin Diagn Pathol. 1985;2:255-269.
5. Auten RL, Watkins RH, Shapiro DL, et al. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am J Respir Cell Mot Biol. 1990;3:491-496.
6. Balis JU, Paterson JF, Paciga JE, et al. Distribution and subcellular localization of surfactant-associated glycoproteins in human lung. Lab Invest. 1985;52:657-669.
7. Broers JL, Jensen SM, Travis WD, et al. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest. 1992;66:337-346.
8. Singh G, Katyal SL. Surfactant apoprotein in nonmalignant pulmonary disorders. Am J Pathol. 1980;101:51-62.
9. Uzaslan E, Ebsen M, Freudenberg N, et al. Reactive alveolar epithelium in chondroid hamartoma of the lung. Acta Cytol. (in press).
10. Chung JH, Kitaichi M, Ham EK, et al. Immunohistochemical localization of surfactant apoproteins in usual interstitial pneumonia associated with pulmonary carcinoma. Microsc Res Tech. 1998;42:234-238.
11. Hegg CA, Flint A, Singh G. Papillary adenoma of the lung. Am J Clin Pathol. 1992;97:393-397.
12. Fine G, Chang CH. Adenoma of type 2 pneumocytes with oncocytic features. Arch Pathol Lab Med. 1991;115:797-801.
13. Nagata N, Dairaku M, Sueishi K, et al. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells. Am J Clin Pathol. 1987;88:552-559.
14. Dairaku M, Sueishi K, Tanaka K, et al. Immunohistological analysis of surfactant-apoprotein in the bronchiolo-alveolar carcinoma. Virchows Arch A Pathol Anat Histopathol. 1983;400:223-234.
15. Singh G, Scheithauer BW, Katyal SL. The pathobiologic features of carcinomas of type II pneumocytes. An immunocytologic study. Cancer. 1986;S7:994-999.
16. Gazdar AF, Linnoila RI, Kurita Y, et al. Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res. 1990;50:5481-5487.
17. Kaufmann O, Dietel M. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology. 2000;36:8-16.
18. Kitinya JN, Sueishi K, Tanaka K, et al. Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung. Acta Pathol Jpn. 1986;36:1271-1278.
19. Komatsu H, Katayama T, Murakami K, et al. [Immunohistochemical study of lung cancer using monoclonal antibody against human pulmonary surfactant apoprotein]. Nippon Kyobu Geka Gakkai Zasshi. 1991;39:2172-2175.
20. Linnoila RI, Mulshine JL, Steinberg SM, et al. Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. J Natl Cancer Inst Monogr. 1992;13:61-66.
21. Nicholson AG, McCormick CJ, Shimosato Y, et al. The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours. Histopathology. 1995;27:57-60.
22. Zamecnik J, Kodet R. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Virchows Arch. 2002;440:353-361.
23. Suehiro T, Maeda K, Suesishi K. Immunohistochemical study of lung adenocarcinoma using monoclonal antibody for 60- kilodalton antigen in type II pneumocytes and nonciliated bronchiolar epithelial cells. Am J Clin Pathol. 1989;92:150-158.
24. Sugiyama K, Kawai T, Nakanishi K, et al. Histochemical reactivities of lectins and surfactant apoprotein in pulmonary adenocarcinomas and their metastases. Mod Pathol 1992;5:273-276.
25. Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary rung adenocarcinoma. Br J Cancer. 2003;88:1229-1233.
26. Uzaslan E, Stuempel T, Ebsen M, et al. Surfactant protein A (SP-A) detection in primary pulmonary pulmonary adenocarcinoma without bronchioloalveolar pattern. Respiration (Herrlisheim). (in press).
27. Linnoila RI, Jensen SM, Steinberg SM, et al. Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol. 1992;97:233-247.
28. Mizutani Y, Nakajima T, Morinaga S, et al. Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus-producing lung adenocarcinomas. Cancer. 1988;61:532-537.
29. Chieng DC, Cangiarella JF, Zakowski MF, et al. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer. 2001;93:330-336.
30. Bross KJ, Pangalis GA, Staatz CG, et al. Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation. 1978;5:331-334.
31. Guzman J, Wang YM, Kalaycioglu O, et al. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonias. Acta Cytol. 1992;36:668-673.
32. Singh G, Katyal SL, Ordonez NG, et al. Type II pneumocytes in pulmonary tumors. Implications for histogenesis. Arch Pathol Lab Med. 1984;108:44-48.
33. Mori M, Tezuka F, Chiba R, et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics. Cancer. 1996;77:665-674.
34. Ten Have-Opbroek AA, Benfield JR, van Krieken JH, et al. The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol. 1997;12:319-336.